TNF-α transgenic and knockout models of CNS inflammation and degeneration

Tumour necrosis factor-alpha (TNF-alpha) plays a central role in inflammatory events including those taking place in the central nervous system (CNS), and has been implicated as a key pathogenic mediator in several human inflammatory, infectious and autoimmune CNS disorders. Using transgenic and gene knockout mice we have investigated the role of deregulated TNF-alpha production in the CNS. We show that the overexpression of wild-type murine or human TNF-alpha transgenes by resident CNS astrocytes or neurons in sufficient to trigger a neurological disorder characterised by ataxia, seizures and paresis, with histopathological features of chronic CNS inflammation and white matter degeneration. Furthermore, we show that transmembrane human TNF-alpha is sufficient to trigger CNS inflammation and degeneration when overexpressed by astrocytes but not by neurons, indicating that target cells mediating the neuroinflammatory activities of TNF-alpha localise in the vicinity of astrocytes rather than neurons. Our results establish that both soluble and transmembrane molecular forms of TNF-alpha can play critical roles in vivo in the pathogenesis of CNS inflammation and demyelination, and validate TNF-alpha transgenic and mutant mice as important models for the further study of related human CNS diseases.

[1]  J. Louis,et al.  CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death , 1993, Science.

[2]  C. Perez,et al.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.

[3]  A. Fontana,et al.  The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis , 1995, Nature Medicine.

[4]  P. Linsley,et al.  Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Saper,et al.  Distribution and characterization of tumor necrosis factor‐α‐like immunoreactivity in the murine central nervous system , 1993 .

[6]  L. Gooding,et al.  A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact , 1990, Cell.

[7]  George Kollias,et al.  The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.

[8]  G. Kollias,et al.  Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. , 1997, Journal of immunology.

[9]  M. Mattson,et al.  Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis , 1994, Neuron.

[10]  K. Frei,et al.  Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells , 1987 .

[11]  R. Ransohoff,et al.  Chemokines in immune-mediated inflammation of the central nervous system. , 1996, Cytokine & growth factor reviews.

[12]  G. Kollias,et al.  Tumour necrosis factors in immune regulation: everything that's interesting is...new! , 1996, Cytokine & growth factor reviews.

[13]  E. Chen,et al.  Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Ballestas,et al.  Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-γ in astrocytes , 1994, Journal of Neuroimmunology.

[15]  M. Hart,et al.  CNS antigen presentation , 1995, Trends in Neurosciences.

[16]  M. Shin,et al.  Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. , 1987, Journal of immunology.

[17]  V. Perry,et al.  Inflammation in the nervous system , 1995, Current Opinion in Neurobiology.

[18]  R. Davis,et al.  Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Cross,et al.  Anti—tumor necrosis factor therapy abrogates autoimmune demyelination , 1991, Annals of neurology.

[20]  D. Kioussis,et al.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.

[21]  D. Kioussis,et al.  Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. , 1993, Journal of immunology.

[22]  R. Clark,et al.  An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis , 1990, The Journal of experimental medicine.

[23]  K. Frei,et al.  Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10 , 1993, The Journal of experimental medicine.

[24]  G. Kollias,et al.  Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Raine.  Multiple sclerosis: TNF revisited, with promise , 1995, Nature Medicine.

[26]  B. Scallon,et al.  Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Brosnan,et al.  Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. , 1991, Journal of Immunology.

[28]  A. Mantovani,et al.  Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes. , 1990, Immunology.

[29]  C. Brosnan,et al.  Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. , 1990, Journal of immunology.

[30]  G. Kollias,et al.  Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. , 1996, Journal of inflammation.

[31]  R. Flavell,et al.  Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. , 1993, Journal of immunology.

[32]  P. Vassalli,et al.  Tumor‐Necrosis Factor and other Cytokines in Cerebral Malaria: Experimental and Clinical Data , 1989, Immunological reviews.

[33]  J. Merrill.  Effects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. , 1991, Developmental neuroscience.

[34]  L. Steinman,et al.  The T lymphocyte in experimental allergic encephalomyelitis. , 1990, Annual review of immunology.

[35]  M. Ueffing,et al.  Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. , 1995, Blood.

[36]  R. Zinkernagel,et al.  Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients , 1988, The Journal of experimental medicine.

[37]  G. Duff,et al.  Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. , 1995, Journal of inflammation.

[38]  M. Mattson,et al.  Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors , 1996, Nature Medicine.

[39]  D. Barten,et al.  Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis , 1994, Journal of Neuroimmunology.

[40]  W. Fiers,et al.  Two tumour necrosis factor receptors: structure and function. , 1995, Trends in cell biology.

[41]  R. Zinkernagel,et al.  Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.

[42]  M. Shin,et al.  Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Kollias,et al.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.

[44]  K. Selmaj,et al.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.

[45]  K. Selmaj,et al.  Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I , 1995, Journal of Neuroimmunology.

[46]  R. Strieter,et al.  Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells , 1995, Journal of Neuroimmunology.

[47]  B. Scallon,et al.  Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor‐immunoglobulin fusion proteins , 1994, European journal of immunology.

[48]  D. Ferrari,et al.  Activation of microglial cells by β-amyloid protein and interferon-γ , 1995, Nature.

[49]  L. Ignarro,et al.  Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. , 1993, Journal of immunology.

[50]  C. Raine,et al.  Cytokines up-regulate Ia expression in organotypic cultures of central nervous system tissue , 1989, Journal of Neuroimmunology.

[51]  R. Janzer,et al.  Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.

[52]  L. Orci,et al.  Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes , 1992, The Journal of experimental medicine.

[53]  L. Steinman,et al.  Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen , 1993, Nature.